| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 06/15/2011 | EP2331514A2 Cyclic polyamines for binding phosphatidylserine |
| 06/15/2011 | EP2331064A1 Brachytherapy seed with fast dissolving matrix for optimal delivery of radionuclides to cancer tissue |
| 06/15/2011 | CN102099059A Small molecule ligand-drug conjugates for targeted cancer therapy |
| 06/14/2011 | US7960334 Use of ADNF III polypeptides for treating mental diseases and disorders, including schizophrenia |
| 06/14/2011 | US7960163 Matriptase, a serine protease and its applications |
| 06/14/2011 | US7959900 Particulate materials and compositions for radio therapy |
| 06/14/2011 | CA2475534C Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy |
| 06/14/2011 | CA2458267C Bifunctional chelating agent for actinium |
| 06/14/2011 | CA2400888C Bifunctional chelating agent |
| 06/14/2011 | CA2369622C Novel method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-egp-2 scfv fragment |
| 06/09/2011 | WO2011068965A1 Methods and compositions for improved f-18 labeling of proteins, peptides and other molecules |
| 06/09/2011 | WO2011068845A1 Combining radioimmunotherapy and antibody-drug conjugates for improved cancer therapy |
| 06/09/2011 | WO2011068181A1 Method for high-speed fluoromethylation and process for preparation of pet tracer using same |
| 06/09/2011 | WO2011045454A3 Multifunctional nanostructures as spect/mri bimodal diagnosis agents |
| 06/09/2011 | WO2011035024A3 Unsealed, non-colloidal radiopharmaceutical compositions and methods for treatment of abnormal tissue |
| 06/09/2011 | US20110136746 Kallikrein-Binding "Kunitz Domain" Proteins and Analogues Thereof |
| 06/09/2011 | US20110136173 Novel Method for the Stabilization of Chimeric Immunoglobulins or Immunoglobulin Fragments, and Stabilized Anti-EGP-2 SCFV Fragment |
| 06/09/2011 | US20110135660 Prevention and treatment of synucleinopathic disease |
| 06/09/2011 | US20110135571 Hybrid nanoparticles as anti-cancer therapeutic agents and dual therapeutic/imaging contrast agents |
| 06/09/2011 | US20110135570 Anti-Tumor Cell Antigen Antibody Therapeutics |
| 06/09/2011 | US20110135569 Method for therapeutic administration of radionucleosides |
| 06/09/2011 | US20110135568 Thickened beverages for dysphagia |
| 06/09/2011 | CA2782223A1 Methods and compositions for improved f-18 labeling of proteins, peptides and other molecules |
| 06/09/2011 | CA2782194A1 Combining radioimmunotherapy and antibody-drug conjugates for improved cancer therapy |
| 06/08/2011 | EP2330208A1 Nanoparticles comprising RNA ligands |
| 06/08/2011 | EP2330130A1 Human monoclonal antibodies against CD20 |
| 06/08/2011 | EP2330127A2 Kallikrein-inhibiting Kunitz Domain proteins and nucleic acids encoding the same |
| 06/08/2011 | EP2329847A2 Use of an antibody or an immunotoxin that selectively binds to CD123 to impair hematologic cancer progenitor cells |
| 06/08/2011 | EP2328891A1 New benzofurans suitable as precursors to compounds that are useful for imaging amyloid deposits |
| 06/08/2011 | EP2328622A1 Radiolabeled annexins |
| 06/08/2011 | EP2328620A2 Active particles for bio-analytical applications and methods for their preparation |
| 06/08/2011 | CN102089010A Dicabba-analogues of octreotide |
| 06/08/2011 | CN101575355B <99m>Tc marked daunorubicin dithiocarbamate composition and preparation method and applications thereof |
| 06/07/2011 | CA2404431C Guanylyl cyclase c in the detection of stomach and esophageal cancers |
| 06/02/2011 | US20110129419 In vivo imaging agents |
| 06/02/2011 | US20110129418 Brain Tumor Targeting Peptides and Methods |
| 06/02/2011 | US20110129417 Administrable compositions |
| 06/02/2011 | US20110129416 Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers |
| 06/02/2011 | US20110129415 Novel antibody and use in diagnosis and therapy of arthropathies |
| 06/02/2011 | US20110129414 Single Chain Fragment of Monoclonal Antibody 9B9 and Uses Thereof |
| 06/02/2011 | US20110129413 Bioconjugation of Calcium Phosphosilicate Nanoparticles For Selective Targeting of Cells In Vivo |
| 06/02/2011 | US20110129412 Antibodies Directed to CD20 and Uses Thereof |
| 06/01/2011 | EP2327451A2 Method for detecting and inhibiting angiogenesis |
| 06/01/2011 | EP2015775B1 Combination of an anti edb fibronectin domain antibody l19-sip and an anti-egfr antibody |
| 06/01/2011 | CN102083773A {F-19} -labeled L-glutamic acid and L-glutamine derivative (III), use thereof and method for obtaining them |
| 06/01/2011 | CN102083772A Novel [F-18] -labelled L-glutamic acid- and L-glutamine derivatives (I), use thereof and method for their production |
| 06/01/2011 | CN102083427A Inhibitors of carbonic anhydrase IX |
| 06/01/2011 | CN101585815B Benzene sulfonic amide compound and intermediate thereof as well as preparation method and application thereof |
| 05/31/2011 | US7951921 Multivalent carriers of bi-specific antibodies |
| 05/31/2011 | US7951774 Stereochemically defined dipeptide esters of antiviral agents for enhanced ocular treatment |
| 05/31/2011 | US7951402 Drug delivery particle |
| 05/31/2011 | US7951369 Chimeric, human and humanized anti-granulocyte antibodies and methods of use |
| 05/31/2011 | CA2319080C Multivalent antibacterial agents |
| 05/26/2011 | WO2011061154A1 Iodine-labeled homoglutamic acid and glutamic acid derivatives |
| 05/26/2011 | WO2010049819A8 Use of 7-chloro-n,n,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4h-pyridazino[4,5-b]indole-1-acetamide as a biomarker of peripheral benzodiazepine receptor levels |
| 05/26/2011 | US20110123988 Antisense compounds and methods for diagnostic imaging |
| 05/26/2011 | US20110123601 Biofunctionalized phospholipid-capped mesoporous silica nanoshuttles for targeted drug delivery |
| 05/26/2011 | US20110123552 Agonistic binding molecules to the human OX40 receptor |
| 05/26/2011 | US20110123446 Degradable compounds and methods of use thereof, particularly with particle replication in non-wetting templates |
| 05/26/2011 | US20110123445 Treatment monitoring |
| 05/26/2011 | US20110123444 Use of radioactively labelled molecule specifically binding to ED-B fibronection in a method of treatment of Hodgkin lymphoma |
| 05/26/2011 | US20110123443 Pancreatic beta-cell mass biomarker |
| 05/26/2011 | US20110123442 Tumor specific antibodies and uses therefor |
| 05/26/2011 | US20110123441 Novel greb1a monoclonal antibody |
| 05/26/2011 | US20110123440 Altered Antibody FC Regions and Uses Thereof |
| 05/26/2011 | US20110123439 Dual-Modality PET/MRI Contrast Agents |
| 05/26/2011 | US20110123438 Universal anchor peptide for nanoparticles |
| 05/26/2011 | US20110123437 Combinatorial therapies for the treatment of neoplasias using the opioid growth factor receptor |
| 05/26/2011 | US20110123436 Dock-and-Lock (DNL) Complexes for Delivery of Interference RNA |
| 05/26/2011 | US20110123435 Compounds for inhibiting ksp kinesin activity |
| 05/26/2011 | US20110123434 Combination therapies comprising quinoxaline inhibitors of p13k-alpha for use in the treatment of cancer |
| 05/26/2011 | CA2780930A1 Method for production of f-18 labeled glutamic acid derivatives |
| 05/26/2011 | CA2780840A1 Iodine-labeled homoglutamic acid and glutamic acid derivatives |
| 05/25/2011 | EP2325642A1 Use of multimodality nanostructures to detect target substances |
| 05/25/2011 | EP2325205A2 Crystals of whole antibodies and fragments thereof and methods for making and using them |
| 05/25/2011 | EP2324857A1 Imaging agents for early detection of cardiovascular plaque |
| 05/25/2011 | EP2323697A2 Imaging agents useful for identifying ad pathology |
| 05/25/2011 | EP1263463B1 Use of an antibody or an immunotoxin that selectively binds to cd123 to impair hematologic cancer progenitor cells |
| 05/25/2011 | CN1972718B Technetium-and rhenium-bis(heteroaryl) complexes, and methods of use thereof |
| 05/25/2011 | CN102070747A Polymer for fluorescein angiogram and isotope angiogram |
| 05/24/2011 | US7947838 Radiolabelled benzamide analogues, their synthesis and use in diagnostic imaging |
| 05/24/2011 | US7947513 Sets and compositions pertaining to analyte determination |
| 05/24/2011 | US7947309 Use of hyaluronic acid polymers for mucosal delivery of vaccine antigens and adjuvants |
| 05/24/2011 | US7947253 Perturbed membrane-binding compounds and methods of using the same |
| 05/24/2011 | CA2339487C Targeting and prolonging association of drugs to the luminal surface of the pulmonary vascular endothelial cells |
| 05/19/2011 | WO2011058002A1 Labelled pyrrolyl-oxadiazolyl-diazabicyclononane derivatives and their use in diagnostic methods |
| 05/19/2011 | WO2011057986A1 Homoglutamic acid derivatives |
| 05/19/2011 | US20110118532 Brachytherapy seed |
| 05/19/2011 | US20110117105 Method of treating immune disease using b-cell antibodies |
| 05/19/2011 | US20110117016 Diagnostic compounds |
| 05/19/2011 | US20110117015 Diagnostic Agents Selective Against Metalloproteases |
| 05/19/2011 | US20110117014 Non-invasive diagnostic agents and methods of diagnosing infectious disease |
| 05/19/2011 | US20110117013 Compositions against cancer antigen liv-1 and uses thereof |
| 05/19/2011 | US20110117012 Radiolabeled gallium complexes, methods for synthesis and use for pet imaging of egfr expression in malignant tumors |
| 05/19/2011 | US20110117011 Neutralizing proprotein convertase subtilisin kexin type 9 (pcsk9) variants and uses thereof |
| 05/19/2011 | US20110117010 Methods and Compositions for Administering Therapeutic and Diagnostic Agents |
| 05/19/2011 | US20110117009 Drug conjugates with polyglycerols |
| 05/19/2011 | US20110117008 Use of avicins to deliver therapeutic and diagnostic agents |
| 05/19/2011 | CA2780282A1 Homoglutamic acid derivatives |
| 05/19/2011 | CA2780243A1 Compositions and methods for inhibiting cellular adhesion or directing diagnostic or therapeutic agents to rgd binding sites |